• BusinessMore>>

  • Get ready for 'Bongzilla,' selfie frenzy at Vegas pot museum

    Get ready for 'Bongzilla,' selfie frenzy at Vegas pot museum

    Thursday, September 20 2018 2:28 AM EDT2018-09-20 06:28:05 GMT
    Thursday, September 20 2018 2:42 PM EDT2018-09-20 18:42:08 GMT
    (AP Photo/John Locher). In this Tuesday, Sept. 18, 2018 photo, Gabe Williams works on a exhibit at the Cannabition cannabis museum in Las Vegas. The museum celebrating all things cannabis with displays that include a glass bong taller than a giraffe an...(AP Photo/John Locher). In this Tuesday, Sept. 18, 2018 photo, Gabe Williams works on a exhibit at the Cannabition cannabis museum in Las Vegas. The museum celebrating all things cannabis with displays that include a glass bong taller than a giraffe an...
    A museum celebrating all things cannabis with displays that include a glass bong taller than a giraffe and huggable faux marijuana plants is the newest tourist attraction in Las Vegas.
    A museum celebrating all things cannabis with displays that include a glass bong taller than a giraffe and huggable faux marijuana plants is the newest tourist attraction in Las Vegas.
  • Colorado meatpacker recalls ground beef after E. coli death

    Colorado meatpacker recalls ground beef after E. coli death

    Thursday, September 20 2018 12:08 PM EDT2018-09-20 16:08:28 GMT
    Thursday, September 20 2018 2:41 PM EDT2018-09-20 18:41:18 GMT
    A Colorado company has recalled more than 132,000 pounds of ground beef after an E. coli outbreak that killed one person and sickened 17.
    A Colorado company has recalled more than 132,000 pounds of ground beef after an E. coli outbreak that killed one person and sickened 17.
  • Biopharmaceutical company fined for misleading investors

    Biopharmaceutical company fined for misleading investors

    Wednesday, September 19 2018 12:38 PM EDT2018-09-19 16:38:11 GMT
    Thursday, September 20 2018 2:41 PM EDT2018-09-20 18:41:10 GMT
    A Colorado-based biopharmaceutical company must pay more than $20 million for misleading investors about the efficacy of a lung cancer drug under development before raising $300 million in a public stock offering.
    A Colorado-based biopharmaceutical company must pay more than $20 million for misleading investors about the efficacy of a lung cancer drug under development before raising $300 million in a public stock offering.
INFORMATIONAL DISCLAIMER The information contained on or provided through this site is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional financial or accounting advice. Always seek the advice of your accountant or other qualified personal finance advisor for answers to any related questions you may have. Use of this site and any information contained on or provided through this site is at your own risk and any information contained on or provided through this site is provided on an "as is" basis without any representations or warranties.
sorry to interrupt
your first 20 are free
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please enjoy 20 complimentary views of articles, photos, and videos during the next 30 days.
you have reached your 20 view limit
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please login or create an account to continue enjoying News12.
Our sign-up page is undergoing maintenance and is not currently available. However, you will be given direct access to news12.com while we complete our upgrade.
When we are back up and running you will be prompted at that time to complete your sign in. Until then, enjoy the local news, weather, traffic and more that's "as local as local news gets."